» Authors » A E van der Meulen

A E van der Meulen

Explore the profile of A E van der Meulen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 23
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nooij S, Plomp N, Sanders I, Schout L, van der Meulen A, Terveer E, et al.
Nat Commun . 2025 Jan; 16(1):1182. PMID: 39885121
Ruminococcus gnavus is a gut bacterium found in > 90% of healthy individuals, but its increased abundance is also associated with chronic inflammatory diseases, particularly Crohn's disease. Nevertheless, its global...
2.
Kreijne J, Goetgebuer R, Erler N, de Boer N, Siebers A, Dijkstra G, et al.
Aliment Pharmacol Ther . 2023 May; 58(2):207-217. PMID: 37221820
Background: Women with inflammatory bowel disease (IBD) are at increased risk of high-grade cervical intraepithelial neoplasia and cervical cancer (CIN2+). Aim: To assess the association between cumulative exposure to immunomodulators...
3.
Goetgebuer R, Kreijne J, Aitken C, Dijkstra G, Hoentjen F, de Boer N, et al.
J Crohns Colitis . 2021 Feb; 15(9):1464-1473. PMID: 33609353
Background And Aims: Women with inflammatory bowel disease [IBD] may be at higher risk for cervical intraepithelial neoplasia [CIN]. However, data are conflicting. The aim of this study was to...
4.
Voskuil M, Spekhorst L, van der Sloot K, Jansen B, Dijkstra G, van der Woude C, et al.
J Crohns Colitis . 2020 Nov; 15(6):930-937. PMID: 33152062
Background And Aims: Inflammatory bowel disease [IBD] phenotypes are very heterogeneous between patients, and current clinical and molecular classifications do not accurately predict the course that IBD will take over...
5.
Westerouen van Meeteren M, Hayee B, Inderson A, van der Meulen A, Altwegg R, Van Hoek B, et al.
J Crohns Colitis . 2017 May; 11(9):1146-1151. PMID: 28482085
Background And Aim: Little is known about the risk of serious infection when combining anti-tumour necrosis factor [TNF] therapy for refractory inflammatory bowel disease [IBD] with immunosuppression after liver transplantation...